YOLFTbeta
Hengkang Medical Group Co Ltd

Hengkang Medical Group Co Ltd

002219 · SHE · Healthcare / Medical Care Facilities

1.88CNY-0.04 (-2.08%)

Price History

Full chart

Market Stats

Previous Close1.92
Open1.93
Day Range1.87 – 1.93
52-Week Range1.69 – 2.97
Volume57.28M
Market Cap7.25B
P/E (TTM)210.00
Forward P/E38.31
EPS0.01
Dividend Yield0.00%
Beta0.22
50-Day Avg2.17
200-Day Avg2.24

About

New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as oncology, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiwei capsules, Ginsengqi Astragalus and Schisandra tablets, Maiping tablets, Qianlie Antong tablets, Prosta Antong tablets, Gongliuning capsules, cough and phlegm granules, cold and flu granules, Wuhu San, Wei Funing capsules, and other proprietary Chinese medicine products. In addition, it engages in cultivation of Chinese herbal medicine; investment management; retail business; wholesale trading activities; and provision of resident services. The company was formerly known as Hengkang Medical Group Co.,Ltd. New Journey Health Technology Group Co.,LTD was founded in 2001 and is headquartered in Beijing, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Liu Jun
  • Employees8.84K
  • HeadquartersFortune Financial Center, Beijing, China, 100020, China
  • Websitehttps://www.njhtg.com

Leadership

  • Mr. Liu JunAccounting Supervisor & Chief Financial Officer · b. 1979
  • Ms. Lihua SongSenior VP & Non-Independent Director · b. 1963
  • Mr. Chen NieVice President · b. 1967
  • Mr. Xu XuVP & Secretary of the Board of Director · b. 1983
  • Mr. Dian ZhuVice President · b. 1982

Financials

Income Statement

Currency: CNY2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue83.97M100.23M130.10M198.23M284.97M285.12M299.33M307.24M336.96M564.73M685.66M1.18B2.18B3.40B3.84B3.68B2.81B3.02B3.16B3.91B3.80B3.05B
Growth (%)-+19.35%+29.81%+52.36%+43.76%+0.05%+4.99%+2.64%+9.67%+67.59%+21.41%+72.35%+84.07%+56.27%+12.92%-4.01%-23.85%+7.49%+4.80%+23.83%-2.95%-19.64%
Cost of Revenue45.50M59.03M79.99M101.99M129.31M119.12M108.87M107.03M126.56M174.65M275.40M629.81M1.39B2.32B3.19B2.72B2.02B2.21B2.17B2.74B2.62B2.17B
Gross Profit38.47M41.20M50.12M96.24M155.66M166.00M190.46M200.22M210.40M390.07M410.26M551.92M782.96M1.08B650.65M968.45M790.33M807.44M992.42M1.17B1.18B879.35M
Gross Margin45.81%41.10%38.52%48.55%54.62%58.22%63.63%65.17%62.44%69.07%59.83%46.70%35.99%31.79%16.95%26.28%28.17%26.77%31.40%29.96%30.97%28.81%
Operating Expense24.79M22.40M28.86M58.40M109.88M112.76M116.47M125.85M130.94M189.05M128.14M223.86M352.94M781.95M1.95B3.37B650.73M1.22B803.24M1.14B1.01B603.77M
Operating Income13.68M18.80M21.26M37.84M45.78M53.23M73.99M74.36M79.46M201.02M282.12M328.06M430.02M298.76M-1.30B-2.40B139.60M-408.23M189.18M37.71M162.45M275.58M
Operating Margin16.29%18.76%16.34%19.09%16.06%18.67%24.72%24.20%23.58%35.60%41.15%27.76%19.77%8.79%-33.79%-65.24%4.98%-13.54%5.98%0.96%4.28%9.03%
EBITDA19.11M25.53M28.38M42.23M59.30M59.76M95.56M106.44M119.00M258.50M356.17M515.84M586.34M716.99M-687.66M-1.95B320.34M35.30M487.44M342.44M451.67M401.71M
EBITDA Margin22.76%25.48%21.81%21.30%20.81%20.96%31.93%34.64%35.31%45.77%51.95%43.65%26.96%21.09%-17.92%-53.03%11.42%1.17%15.42%8.75%11.89%13.16%
Net Income13.73M17.58M19.26M33.80M44.51M47.81M65.96M71.35M73.67M169.83M257.33M323.63M403.63M202.81M-1.42B-2.52B-52.24M-371.43M156.12M28.97M114.77M30.94M
Net Income Margin16.35%17.54%14.80%17.05%15.62%16.77%22.04%23.22%21.86%30.07%37.53%27.39%18.56%5.97%-36.94%-68.38%-1.86%-12.32%4.94%0.74%3.02%1.01%
R&D---2.15M2.50M-8.72M9.59M8.50M9.37M8.80M7.73M1.01M447.64K8.27M1.29M296.94K444.48K26.37M27.71M9.86M13.35M
R&D as % of Total Revenue---1.09%0.88%-2.91%3.12%2.52%1.66%1.28%0.65%0.05%0.01%0.22%0.04%0.01%0.01%0.83%0.71%0.26%0.44%
Interest Expense751.18K1.34M1.59M1.11M975.79K25.02K1.54M2.16M5.36M13.99M25.13M45.78M23.85M213.49M415.85M348.73M139.69M234.85M143.90M123.53M137.72M123.43M
Interest Expense % of Total Revenue0.89%1.34%1.22%0.56%0.34%0.01%0.51%0.70%1.59%2.48%3.67%3.87%1.10%6.28%10.83%9.46%4.98%7.79%4.55%3.16%3.63%4.04%

Balance Sheet

Currency: CNY2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets153.01M157.66M187.31M236.42M358.91M452.43M513.36M600.80M869.10M1.14B1.89B4.78B5.98B10.25B8.76B4.91B4.82B6.69B5.64B6.08B6.68B6.65B
Total Liabilities80.92M67.99M78.38M93.70M46.91M97.86M99.18M123.64M308.45M322.29M836.05M977.44M1.81B5.91B5.90B4.70B4.66B5.10B3.88B3.85B4.64B4.64B
Total Equity72.09M89.67M108.93M142.72M311.99M354.57M414.18M477.16M544.48M803.13M1.02B3.73B4.08B4.19B2.71B194.80M133.85M1.55B1.72B2.20B1.98B1.95B
Cash5.93M11.15M33.52M60.81M110.85M88.26M112.04M212.58M300.72M110.82M193.42M1.02B705.38M594.38M347.29M122.35M171.65M2.03B558.91M580.24M471.53M393.49M
Total Debt26.00M12.00M26.60M45.00M-30.00M20.00M50.00M190.00M151.04M476.79M132.57M909.91M3.34B3.13B2.85B2.43B2.44B1.58B1.57B1.41B-
Net Debt20.07M850.03K-6.92M-15.81M-110.85M-58.26M-92.04M-162.58M-110.72M40.22M283.38M-882.74M204.53M2.74B2.79B2.73B2.25B405.78M1.02B966.44M939.85M995.33M

Cash Flow

Currency: CNY2004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow76.41K36.54M13.55M31.88M22.37M32.63M64.43M94.80M82.71M158.40M193.35M219.02M-697.37M-204.82M522.57M549.51M283.80M277.29M268.04M290.98M438.51M293.79M
Investing Cash Flow-271.74K-668.87K-849.99K-14.75M-51.11M-84.80M-28.80M-9.40M-73.73M-333.15M-420.64M-1.22B-637.52M-2.49B-237.85M-276.03M-77.05M-199.09M-192.31M-335.38M-490.31M-
Financing Cash Flow1.19M-30.65M9.67M10.16M78.78M29.59M-11.84M15.14M79.16M-15.14M308.27M1.82B603.07M3.01B-550.98M-585.59M-174.66M1.77B-1.53B62.82M-109.73M-
Capital Expenditure271.74K668.87K849.99K14.65M55.72M85.49M28.82M9.46M9.07M137.26M25.74M445.49M279.64M573.57M220.41M215.74M216.57M198.73M221.57M195.17M307.44M257.00M
Free Cash Flow-195.32K35.87M12.70M17.23M-33.35M-52.86M35.60M85.35M73.64M21.14M167.61M-226.47M-977.01M-778.38M302.15M333.78M67.23M78.56M46.47M95.81M131.06M36.78M
Dividends Paid675.86K1.48M1.59M1.03M975.79K597.76K1.92M14.86M12.59M13.99M57.38M45.15M17.59M199.24M324.68M394.92M83.95M54.18M275.82M103.99M118.24M100.71M
FCF to OCF-255.61%98.17%93.73%54.05%-149.10%-162.02%55.26%90.02%89.03%13.35%86.69%-103.40%140.10%380.04%57.82%60.74%23.69%28.33%17.34%32.93%29.89%12.52%
Dividend Paid to FCF-346.02%4.11%12.49%5.98%-2.93%-1.13%5.40%17.42%17.10%66.17%34.23%-19.93%-1.80%-25.60%107.46%118.32%124.87%68.97%593.61%108.54%90.21%273.79%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Oct 25, 2013Jan 27, 2014Apr 22, 2014Aug 20, 2014Oct 29, 2014Feb 16, 2015Apr 28, 2015Aug 25, 2015Oct 27, 2015Feb 25, 2016Apr 29, 2016Aug 28, 2016Oct 27, 2016Feb 27, 2017Apr 27, 2017Aug 21, 2017Oct 23, 2017Feb 27, 2018Apr 26, 2018Aug 24, 2018Oct 24, 2018Apr 30, 2019Aug 28, 2019Oct 28, 2019Apr 30, 2020Aug 27, 2020Oct 28, 2020Apr 28, 2021Aug 27, 2021Oct 29, 2021Apr 29, 2022Aug 26, 2022Oct 28, 2022Apr 25, 2023Aug 12, 2023Oct 27, 2023Apr 17, 2024Aug 22, 2024Oct 26, 2024Apr 28, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------0.030.020.050.060.050.050.080.070.060.06-0.040.080.070.07------------------------------
EPS Actual0.010.010.020.010.000.020.020.010.010.010.010.010.010.010.010.010.030.030.020.020.050.060.040.030.030.010.06-0.090.040.040.030.110.110.050.05-0.030.030.01-0.250.01-0.05-0.06-0.02-0.01-0.00-0.00-0.00-0.01-0.170.020.020.010.01-0.01-0.000.01-0.000.01-0.01-0.010.020.01-0.00
Surprise-------------------33.33%0.00%0.00%0.00%-20.00%-40.00%-62.50%-85.71%0.00%-250.00%--6.00%-62.50%54.57%57.14%------------------------------
Timing------------------After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hours--Pre-market-----Pre-marketPre-market-After-hours-----

Key Statistics & Ratios

Market Cap7.25B
Enterprise Value8.65B
Trailing P/E210.00
Forward P/E38.31
PEG Ratio0.00
Price / Sales2.53
Price / Book3.63
EPS0.01
Book Value0.628
Revenue (TTM)2.87B
Gross Profit (TTM)837.72M
EBITDA348.26M
Profit Margin1.06%
Operating Margin6.33%
Return on Equity1.72%
Return on Assets1.95%
Shares Outstanding3.45B
Shares Float2.02B
Beta0.22
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20141×
0.03Feb 28, 2014
20121×
0.00May 23, 2012
20111×
0.01May 19, 2011
20101×
0.01Sep 29, 2010
20091×
0.01Sep 9, 2009

Stock Splits

  • Oct 28, 201525:10
  • Feb 28, 201414:10
  • May 23, 201211.5:10
  • May 19, 201112.5:10
  • Sep 9, 20092:1